Literature DB >> 15652201

In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.

V R Sinha1, B R Mittal, Rachna Kumria.   

Abstract

Compression coating has been found to be useful for colonic drug delivery. The aim of the present investigation was to evaluate a formulation with a considerably reduced coat weight and gum concentration for colonic drug delivery in vivo using gamma scintigraphy. In vitro studies have found this formulation to be useful for delivery of 5-fluorouracil to the colon. Rapidly disintegrating core tablets containing (99m)Tc-DTPA were prepared and compression coating with 150 mg of granules containing a mixture of xanthan (XG), guar gum (GG) and starch. The ratios of the two gums XG:GG in the coat was kept 10:20. In vitro dissolution studies on XG:GG::10:20 tablets containing (99m)Tc-DTPA were carried out in simulated upper GIT conditions and also in presence of colonic contents. Cumulative percent release of technetium in the upper GIT conditions and transit time amounted to 4%. The total amount of technetium released in the 24 h of the dissolution study was 53+/-3.23%. Upon introduction of cecal content into the dissolution medium (4%), the release of technetium from the compression-coated tablet increased to 78.34+/-5.34%. Gamma scintigraphy studies carried out in six healthy human volunteers showed that the tablet remained intact during its transit through the upper GIT. The anatomical site of disintegration was found to be the ascending colon/hepatic flexure and the disintegration of the tablet started between 4 and 6 h post-dose in all the volunteers with a further spread of tracer into the ascending, transverse, descending and sigmoidal colon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652201     DOI: 10.1016/j.ijpharm.2004.10.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.

Authors:  Siddhartha Maity; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2015-08-14       Impact factor: 3.246

2.  Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.

Authors:  Alaa Eldeen B Yassin; Md Khalid Anwer; Hammam A Mowafy; Ibrahim M El-Bagory; Mohsen A Bayomi; Ibrahim A Alsarra
Journal:  Int J Med Sci       Date:  2010-11-22       Impact factor: 3.738

3.  Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats.

Authors:  J Varshosaz; J Emami; N Tavakoli; M Minaiyan; N Rahmani; F Dorkoosh; P Mahzouni
Journal:  Daru       Date:  2011       Impact factor: 3.117

4.  Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat.

Authors:  Jaleh Varshosaz; Jaber Emami; Naser Tavakoli; Mohsen Minaiyan; Nakisa Rahmani; Farid Dorkoosh; Parvin Mahzouni
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

5.  In Vitro and In Vivo Correlation of Colon-Targeted Compression-Coated Tablets.

Authors:  Siddhartha Maity; Amit Kundu; Sanmoy Karmakar; Biswanath Sa
Journal:  J Pharm (Cairo)       Date:  2016-02-17

6.  Optimization of Chitosan and Cellulose Acetate Phthalate Controlled Delivery of Methylprednisolone for Treatment of Inflammatory Bowel Disease.

Authors:  Swati Jagdale; Apoorva Chandekar
Journal:  Adv Pharm Bull       Date:  2017-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.